Big Move For Acrivon Therapeutics Inc.

Tue, Apr 15, 2025 at 08:04 PM

Acrivon Therapeutics Inc. (ACRV:NASDAQ) soared at $2.15, a gain of 43.3%. On Tue, Apr 15, 2025, ACRV:NASDAQ hit a New 2-Week High of $2.15. The stock got featured on our News Catalysts scanner on Mon, Apr 07, 2025 at 06:15 PM in the 'BIOTECH' category. From Tue, Apr 01, 2025, the stock recorded 40.00% Up Days and 45.45% Green Days

About Acrivon Therapeutics Inc. (ACRV:NASDAQ)

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Company matches to patients whose tumors are predicted to be sensitive to each specific...

Top 10 Gainers:

Ostin Technology Group Co. Ltd. (OST:NASDAQ), 299.1%
Mural Oncology plc (MURA:NASDAQ), 133.98%
ARB IOT Group Limited (ARBB:NASDAQ), 44.71%
Acrivon Therapeutics Inc. (ACRV:NASDAQ), 43.33%
Elong Power Holding Limited (ELPW:NASDAQ), 43.14%
SUNation Energy Inc Com Par $0.05 (SUNE:NASDAQ), 42.86%
Intercont (Cayman) Limited (NCT:NASDAQ), 41.77%
Knightscope Inc. (KSCP:NASDAQ), 41.67%
Dogwood Therapeutics Inc. (DWTX:NASDAQ), 38.67%
Ruanyun Edai Technology Inc. (RYET:NASDAQ), 34.1%